RxDoctor Payments Data

Gail Calvert

Nurse Practitioner · Brookfield, MONPI 1922690254

Payments from drug & device makers

$4,688in general payments, 2019–2025

Across 274 payments — averaging $17.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$457
  • Merck$361
  • Seagen Inc.$357
  • Incyte Corporation$250
  • AstraZeneca$226
  • Amgen$196
  • plus $3K from 47 others

What the payments were for

  • Food & beverage$4,35793%
  • Education$3307%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,688 in reported general payments places this provider in the 90th percentile of 1,898 nurse practitioner providers in Missouri.

See all nurse practitioner providers in Missouri

Medicare billing

Part B allowed, 2024
$49,331
Medicare patients
178
Services billed
1,864

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Avonex (4 Pack)Interferon Beta-1a13$125,079
EliquisApixaban60$56,781
OzempicSemaglutide34$49,514
FarxigaDapagliflozin Propanediol27$27,809
VraylarCariprazine Hcl14$23,509
TrulicityDulaglutide25$22,557
RexultiBrexpiprazole12$16,928
MounjaroTirzepatide13$12,990
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$10,643
XareltoRivaroxaban11$10,493
Aimovig AutoinjectorErenumab-Aooe12$8,883
SymbicortBudesonide/Formoterol Fumarate21$5,854
Spiriva HandihalerTiotropium Bromide11$5,669
Gabapentin90$2,691
Omeprazole136$1,774

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$150$56,78160 claims
Novo NordiskOzempic$91$49,51434 claims
Lilly USA, LLCTrulicity, Mounjaro$116$35,54738 claims
AstraZenecaFarxiga, Symbicort$226$33,66348 claims
AbbVieVraylar$457$23,50914 claims
Otsuka America Pharmaceutical, Inc.Rexulti$174$16,92812 claims
GSKTrelegy Ellipta$13$10,64311 claims
Johnson & JohnsonXarelto$154$10,49311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,898 nurse practitioner providers in Missouri.

Other nurse practitioner in Brookfield

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →